Pierre Fabre Medicament

This study looked back at medical records to describe the types of patients who received the drug neratinib for early-stage HER2-positive breast cancer in Europe. It involved 111 adults who had taken at least one dose of the drug between 2017 and 2020. The goal was to understand …

This study aimed to understand how skin, hair, and itching side effects impact the daily lives of women being treated for early breast cancer. Researchers surveyed 155 women in Europe who had been on a standard hormone therapy for 2-3 years. By having patients fill out detailed q…

This study looked back at the medical records of 274 European patients with a specific, aggressive form of metastatic colon cancer (with a BRAF V600E mutation). The goal was to understand what treatments doctors actually used in the real world between 2016 and 2018, and how well …

This study observed 400 adults in Europe with advanced, hard-to-treat skin cancer (melanoma) who were already receiving standard targeted drug therapy. The goal was to learn about these patients and understand how they used a specific mobile app (TavieSkin) designed to support th…